Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2014

01.12.2014 | Original Article

Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up

verfasst von: Nicolas Bouviez, Zaher Lakkis, Jean Lubrano, Tuxun Tuerhongjiang, Brice Paquette, Bruno Heyd, Georges Mantion

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Actual 5-year survival rates after resection of colorectal liver metastases (CLM) are 25–45 %, whereas 10-year survival rates are extrapolated from survival curves. Few studies have reported long-term survivors with 10 years of actual follow-up. Therefore, no recurrences occurring after 10-plus years have been reported. The aim of our study was to analyze actual 10-year survival rates and prognostic factors.

Methods

Clinical data of patients with CLM who had undergone first liver resection in our center between January 1990 and December 2000 were retrospectively analyzed.

Results

Eighty-nine patients of mean age 64 years were studied. Three patients were excluded from the study: one because of postoperative death, and two from being lost to follow-up. All other subjects had a potential 10-year follow-up. Only 33 % patients received perioperative chemotherapy. The actual 10-year overall and disease-free survival rate were 22 and 19 %, respectively. Poor prognostic factors were disease-free interval less than 1 year, wedge liver resection, clinical risk score >2, segment 1 CLM location, and peritumoral lymphangitis. Good prognostic factors were tumors having mucinous components in primary tumor and CLM located in the right lobe.

Conclusions

With actual long-term follow-up for 10 years, disease-free survival rate is 19 % and mainly depends on surgical management. Recurrence continues to occur more than 5 years after liver resection for CLM; cure cannot be assumed at this time. Clinical risk score is a good predictor of cure and should be taken into account when choosing perioperative treatment.
Literatur
1.
Zurück zum Zitat Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J et al (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55(Suppl 3):iii1–iii8PubMedCentralPubMed Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J et al (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55(Suppl 3):iii1–iii8PubMedCentralPubMed
2.
Zurück zum Zitat Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575–4580PubMedCrossRef Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575–4580PubMedCrossRef
3.
Zurück zum Zitat Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15(9):2458–2464PubMedCrossRef Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15(9):2458–2464PubMedCrossRef
4.
Zurück zum Zitat Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 12(4):244–249 Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 12(4):244–249
5.
Zurück zum Zitat Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–1016PubMedCentralPubMedCrossRef Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–1016PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14(12):1208–1215PubMedCrossRef Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al (2013) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 14(12):1208–1215PubMedCrossRef
7.
8.
Zurück zum Zitat Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318, discussion 318–321PubMedCentralPubMedCrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318, discussion 318–321PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Lopez P, Marzano E, Piardi T, Pessaux P (2012) Repeat hepatectomy for liver metastases from colorectal primary cancer: a review of the literature. J Visc Surg 149(2):e97–e103PubMedCrossRef Lopez P, Marzano E, Piardi T, Pessaux P (2012) Repeat hepatectomy for liver metastases from colorectal primary cancer: a review of the literature. J Visc Surg 149(2):e97–e103PubMedCrossRef
10.
Zurück zum Zitat Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y et al (2003) Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46(2):160–167PubMedCrossRef Kanemitsu Y, Kato T, Hirai T, Yasui K, Morimoto T, Shimizu Y et al (2003) Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46(2):160–167PubMedCrossRef
11.
Zurück zum Zitat Song W, Wu S, He Y, Cai S, Zhang C, Zhang X et al (2009) Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J 122(13):1486–1491PubMed Song W, Wu S, He Y, Cai S, Zhang C, Zhang X et al (2009) Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J 122(13):1486–1491PubMed
12.
Zurück zum Zitat Maksimović S (2007) Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh 61(1):26–29PubMed Maksimović S (2007) Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh 61(1):26–29PubMed
13.
Zurück zum Zitat Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE (1993) Mucinous carcinoma—just another colon cancer? Dis Colon Rectum 36(1):49–54PubMedCrossRef Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE (1993) Mucinous carcinoma—just another colon cancer? Dis Colon Rectum 36(1):49–54PubMedCrossRef
14.
Zurück zum Zitat Kang H, O’Connell JB, Maggard MA, Sack J, Ko CY (2005) A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48(6):1161–1168PubMedCrossRef Kang H, O’Connell JB, Maggard MA, Sack J, Ko CY (2005) A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48(6):1161–1168PubMedCrossRef
15.
Zurück zum Zitat King-Yin Lam A, Ong K, Ho Y-H (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 49(9):1275–1283PubMedCrossRef King-Yin Lam A, Ong K, Ho Y-H (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 49(9):1275–1283PubMedCrossRef
16.
Zurück zum Zitat Elias D, Saric J, Jaeck D, Arnaud JP, Gayet B, Rivoire M et al (1996) Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83(7):942–945PubMedCrossRef Elias D, Saric J, Jaeck D, Arnaud JP, Gayet B, Rivoire M et al (1996) Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83(7):942–945PubMedCrossRef
17.
Zurück zum Zitat Schmidt T, Koch M, Antolovic D, Reissfelder C, Schmitz-Winnenthal FH, Rahbari NN et al (2008) Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination—prospective randomized multicenter trial. BMC Surg 8:6PubMedCentralPubMedCrossRef Schmidt T, Koch M, Antolovic D, Reissfelder C, Schmitz-Winnenthal FH, Rahbari NN et al (2008) Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination—prospective randomized multicenter trial. BMC Surg 8:6PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat (2009) Cancérologie digestive: pratiques chirurgicales. J Chir 146:S11–S80 (2009) Cancérologie digestive: pratiques chirurgicales. J Chir 146:S11–S80
19.
Zurück zum Zitat Abbas S, Lam V, Hollands M (2011) Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis. ISRN Oncol 2011:763245PubMedCentralPubMed Abbas S, Lam V, Hollands M (2011) Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis. ISRN Oncol 2011:763245PubMedCentralPubMed
20.
Zurück zum Zitat Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions. Swiss Surg Suppl 4:4–17 Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions. Swiss Surg Suppl 4:4–17
21.
Zurück zum Zitat Yasui K, Shimizu Y (2005) Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10(2):86–96PubMedCrossRef Yasui K, Shimizu Y (2005) Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10(2):86–96PubMedCrossRef
22.
Zurück zum Zitat Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM (2009) Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 16(2):379–384PubMedCrossRef Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM (2009) Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 16(2):379–384PubMedCrossRef
Metadaten
Titel
Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up
verfasst von
Nicolas Bouviez
Zaher Lakkis
Jean Lubrano
Tuxun Tuerhongjiang
Brice Paquette
Bruno Heyd
Georges Mantion
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2014
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-014-1229-z

Weitere Artikel der Ausgabe 8/2014

Langenbeck's Archives of Surgery 8/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.